[Pediatric exposures to laundry pods or capsules: more toxic than traditional laundry products?]

I Claudet1, R Honorat1, A Casasoprana1

  • 1Service d'accueil des urgences pédiatriques, hôpital des Enfants, CHU de Toulouse, 330, avenue de Grande-Bretagne, TSA 70034, 31059 Toulouse cedex 9, France.

Insights

Laundry pods cause more severe pediatric poisonings than traditional detergents. Increased toxicity is linked to their concentrated chemical composition, necessitating enhanced safety measures and parental awareness.

Area of Science:

  • Toxicology
  • Pediatric Emergency Medicine
  • Consumer Product Safety

Background:

  • New concentrated laundry pods have been on the European market for about 10 years.
  • These pods are associated with more severe intoxications compared to classic laundry detergents.

Purpose of the Study:

  • To compare the symptoms and severity of exposure to classic laundry detergents versus new laundry pods in children.
  • To identify key differences in clinical presentation and outcomes.

Main Methods:

  • A retrospective study was conducted from January 2002 to June 2013.
  • Data from pediatric patients admitted to a tertiary level pediatric emergency unit following laundry detergent exposure were analyzed.
  • Collected data included patient demographics, product type, ingested quantity, clinical symptoms, and severity scores.

Main Results:

  • Eighty-nine children were included, with 65% being under 2 years old.
  • Children exposed to laundry pods were significantly more symptomatic (96% vs. 51%) compared to those exposed to classic detergents.
  • Laundry pod exposure led to more frequent digestive symptoms, bronchospasm, ocular lesions, and overall more severe poisoning outcomes.

Conclusions:

  • Laundry pod toxicity is more severe due to higher concentrations of surfactants and ethoxylated alcohols, increased viscosity, and altered alkalinity.
  • Enhanced reporting to poison centers, parental education on risks, and manufacturer modifications for safety are crucial.
  • Urgent action is needed to improve product safety and child-resistant packaging.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K